Ambrx Biopharma, Inc. (AMAM) has 5 open-market insider trades by 3 insiders since 2023. The most active filer is Cormorant Private Healthcare Fund III LP, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Bihua Chen | 10% Owner | — | 1 | $117.9M | 2023-04-20 |
| Cormorant Private Healthcare Fund III LP | 10% Owner | — | 2 | $60.9M | 2023-04-17 |
| Cormorant Asset Management, LP | 10% Owner | — | 2 | $57.5M | 2023-10-23 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Daniel J. O'Connor | CEO & President | Sell | $982K | 2023-10-27 |
| Sonja Nelson | CFO | Sell | $251K | 2023-10-27 |
| Cormorant Asset Management, LP | 10% Owner | Buy | $18.3M | 2023-10-23 |
| Cormorant Asset Management, LP | 10% Owner | Buy | $39.3M | 2023-09-15 |
| Bihua Chen | 10% Owner | Buy | $117.9M | 2023-04-18 |
| Cormorant Private Healthcare Fund III LP | 10% Owner | Buy | $50.6M |
Companies that share insiders with AMAM, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2023-04-13 |
| Cormorant Private Healthcare Fund III LP | 10% Owner | Buy | $10.2M | 2023-03-14 |